Description
Release form
Solution for oral administration.
Packaging
Bottle 25 ml.
Pharmacological action
Elkar contains L-carnitine. L-carnitine is a natural substance related to the B vitamins. It participates in metabolic processes as a carrier of long chain fatty acids (palmitic, etc.) from the cytoplasm to mitochondria, where these acids undergo a -Oxidation process with the formation of adenosine triphosphoric acid and acetyl-CoA.
Improves protein and fat metabolism, increases the secretion and enzymatic activity of gastric and intestinal juices, improves digestion, reduces overweight and reduces muscle fat. Increases resistance to physical stress, inhibits the formation of keto acids and anaerobic glycolysis, reduces the degree of lactic acidosis, contributes to the economical use of glycogen and increases its reserves in the liver and muscles.
Has anabolic and lipolytic effects. Normalizes the increased main metabolism in hyperthyroidism: It is a peripheral (indirect) antagonist of the action of thyroid hormones, and not a direct inhibitor of thyroid function. Improves metabolism and energy supply of tissues.
Indications
The drug is used as part of complex therapy for:
– Intense physical exertion and psycho-emotional stress: to increase working capacity, stamina, reduce fatigue, including in elderly people.
– During the rehabilitation period after illnesses and surgical interventions, injuries, including to accelerate tissue regeneration.
– Therapy of chronic gastritis and chronic pancreatitis with decreased secretory function.
– Therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus).
– Mild hyperthyroidism.
– Neurological manifestations in vascular, toxic and traumatic brain damage.
– Anorexia Nervous Syndrome.
– Diseases accompanied by a lack of carnitine or its increased loss (myopathy, cardiomyopathy, mitochondrial diseases, hereditary diseases with concomitant mitochondrial insufficiency) – to compensate for its deficiency.
– In pediatric practice (treatment of children under 3 years old under the supervision of a doctor): when nursing premature infants, newborns who have suffered a birth injury or asphyxia for children with a sluggish sucking reflex and low weight gain for children with reduced muscle tone, with insufficient development of motor and mental functions, as well as with the aim of preventing these disorders in children of the risk group with stunting and underweight in children and adolescents under 16 years of age.
– In adults in sports medicine and during intensive training (during the training process when practicing aerobic performance): to improve speed-strength indicators and coordination of movements to increase muscle mass and reduce body fat mass to prevent post-workout syndrome (accelerate recovery processes after physical loads) for traumatic injuries in order to accelerate muscle regeneration.
Contraindications
Individual intolerance.
Special instructions
Treat children under the age of 3 years under the supervision of a doctor.
Influence on the ability to drive vehicles and control mechanisms: the drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving a car and other vehicles, working with moving mechanisms, the work of a dispatcher and operator, etc.)
Composition of
In 1 ml of solution for oral administration contains: levocarnitine (karnifit) 300 mg.
Excipients: citric acid monohydrate 1.2 mg, methyl parahydroxybenzoate 0.5 mg, propyl parahydroxybenzoate 0.2 mg, purified water to 1 ml.
Dosage and administration of
The drug is used as part of complex therapy. Inside 30 minutes before meals, additionally diluting with liquid.
With prolonged physical and psycho-emotional stress: from 0.75 g (1/2 scoop or 2.5 ml) 3 times a day to 2.25 g (1.5 scoop or 7.5 ml) 2-3 times in a day.
In case of anorexia nervosa, as well as during the rehabilitation period after illnesses and surgical interventions and injuries: 1.5 g (1 scoop or 5 ml) 2 times a day. The course of treatment is within 1-2 months.
In the complex treatment of chronic gastritis and chronic pancreatitis with reduced secretory function: 0.375 g (1/4 scoop or 1.25 ml) 2 times a day. The course of treatment is within 1-1.5 months.
For the treatment of skin diseases: 0.75 g (1/2 scoop or 2.5 ml). The course of treatment is within 2-4 weeks.
With mild hyperthyroidism: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.
For vascular, toxic and traumatic brain damage: 0.75 g (1/2 scoop or 2.5 ml) per day. The course of treatment is within 3-5 days. If necessary, after 12-14 days, a second course is prescribed.
For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency): up to 50-100 mg / kg (2-5 drops / kg) of body weight with a frequency of administration of 2-3 times a day. The course of treatment is within 3-4 months.
Children are prescribed as an additive to sweet dishes (kissel, compote, juices): for children under 3 years old, the dose is determined by the attending physician from 3 to 6 years old – in a single dose of 0.1 g (5 drops) 2-3 times a day , in a daily dose of 0.2-0.3 g (11-16 drops). The course of treatment is 1 month for children from 6 to 12 years of age prescribed in a single dose of 0.2-0.3 g (11-16 drops) 2-3 times a day, in a daily dose of 0.4-0.9 g (22- 48 drops). The course of treatment is at least 1 month.
With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.
In sports medicine and during intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In case of use for therapeutic purposes – 70-100 mg / kg / day (5-7.5 g / day). Admission courses: 3-4 weeks in the pre-competition period. During the training process – up to 6-8 weeks.
Side effects of
Possible: allergic reactions, gastralgia, dyspepsia, myasthenia gravis (in patients with uremia)
Drug interaction
Glucocorticosteroids contribute to the accumulation of the drug in tissues (except the liver), other anabolics enhance the effect.
Overdose
Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).
Treatment: gastric lavage, activated carbon intake.
Storage Conditions
Store in a dark place at a temperature of 15 to 25 ° C. After the autopsy – in the refrigerator for 2 months.
Shelf life
3 years.
Deystvuyushtee substance
levocarnitine
Conditions of sale from
pharmacies Without prescription
Dosage form
oral solution
Possible product names
ELKAR 0.3 / ML 25ML FLAC RR
ELKAR RR 20% FL-CAP 25ML
ELKAR RR 30% 25ML (D / INTERNAL APPLICATION) srdlkR RLC 30% 25ML No. 1
Elkar solution inside 300mg / ml vial 25ml
Peak Fa ma, Russia
